Skip to main content

Government News

  • (3rd July, 2014); Four new vaccines are introduced as part of India’s Universal Immunization Programme (UIP), announced by Shri Narendra Modi, Prime Minister of India. Vaccines against rotavirus, rubella and polio (injectable) will collectively expedite India’s progress on meeting the Millennium Development Goal 4 targets to reduce child mortality by two-thirds by the year 2015 and meet global polio eradication targets. In addition, an adult vaccine against Japanese encephalitis will be introduced in districts with high levels of the disease.

  • Health Minister discussed Indian health system & scenarios at Centre for Disease Control and Prevention, Atlanta

    (30th June, 2014); Union Health Minister Dr. Harsh Vardhan held a four hour long meeting with top experts at the world famous Centre for Disease Control and Prevention (CDC) at Atlanta on 28th June.

  • Free drug policy to be streamlined for integration with NHM

    (1st June, 2014); Dr Harsh Vardhan, Union Minister for Health and Family Welfare, has asked for thorough streamlining of systems in the distribution of free generic drugs to government health institutions at all levels throughout the country. The Free Drug Programme’s formal launch would be preceded by working out all logistical details with respect to procurement and distribution in consultation with the state governments.

  • CSIR-IHBT developed unique enzyme for creating global niche

    (11th May, 2014); CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, has developed unique autoclavable Super Oxide Dismutase (SOD) enzyme, used in cosmetic, food and pharmaceutical industries for end applications, like developing anti-ageing creams, extending shelf life of fruits and vegetables and during cryo-surgery and preservation of organelles, respectively.

  • DTAB concern about wide variation in the quality of Generic Drugs

    (28th Apr, 2014); In their last meeting, Drugs Technical Advisory Board (DTAB) raised the issue of wide variation in the quality of generic drugs manufactured in the country by small scale sector. The generic medicines of lower quality have not been found effective in patients.

  • Manufacturers invited to present their proposal in office of DCGI for approval of the safety and efficacy of FDCs

    Fixed Dose Combinations (FDCs) manufacturers are invited to present their proposal for approval of the safety and efficacy of permitted for manufacture for sale in the country without due approval from office of Drug Controller General of India (DCGI).

  • India reaches remarkable milestone as 'Polio Free Nation' certified by WHO

    On thursday, 27th march 2014, the World Health Organisation (WHO) presented official certification to India for its ‘Polio Free’ status. India is among other countries in its South East Asian region which have been certified as being free of the wild polio virus. Ghulam Nabi Azad, health minister of India, received the official certificate from WHO.

  • Health Ministry notified on implementation of Schedule H1 drugs in D&C rules | No more OTC selling of antibiotics

    The Drugs and Cosmetics Rules, 1945 (D&C rules) were amended vide Drugs and Cosmetics (Fourth Amendment) Rules, 2013 published under Gazette notification G.S.R. 588(E) dated 30.08.2013 regarding the inclusion of Schedule H1 under the D&C rules containing certain antibiotics, anti-TB drugs and habit forming drugs. The notification states that these rules will come into force after six months of their publication in the official Gazette i.e. from 1st March, 2014

Subscribe to Government News